Below are the most recently updated broker updates which include ratings and price targets for BG Medicine, Inc. (BGMD).

05/01/2015 – Broker: Zacks Rating: hold reiteration

11/13/2014 – Broker: Ladenburg Thalmann Rating: neutral downgrade

The stock decreased -2.16% (-0.01) during the last days session, reaching 0.34 and roughly 57878 shares were bought or sold by traders.

View other investors thoughts on BG Medicine, Inc. with our new Stock Talk discussion platform. Sign up for free to contribute to the community and view research provided from other investors for any stock listed on the LSE, NYSE or NASDAQ.